1 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Oct 17, 2024
Read More Medical New Developments In Gastric Cancer Research: Keytruda In Combination With Chemotherapy Significantly Improves Survival In Patients With Advanced Disease! Nov 09, 2024
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Medical New Strategies For Cancer Vaccines: Transforming Cancer Cells So They Can Become Cancer-Fighters Is Not Far Away! Nov 07, 2024
